Chilton Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-37
Closed -$10.8K 623
2026
Q1
$10.8K Buy
+37
New +$12.2K ﹤0.01% 459
2025
Q3
Sell
-1
Closed -$389 578
2025
Q2
$389 Buy
+1
New +$402 ﹤0.01% 520
2025
Q1
Sell
-3
Closed -$1.11K 550
2024
Q4
$1.11K Sell
3
-19
-86% -$7.95K ﹤0.01% 529
2024
Q3
$11.4K Hold
22
﹤0.01% 467
2024
Q2
$11.9K Buy
22
+15
+214% +$7.93K ﹤0.01% 483
2024
Q1
$3.63K Hold
7
﹤0.01% 526
2023
Q4
$3.3K Buy
+7
New +$3.24K ﹤0.01% 536

Other funds holding ELV

Chilton Capital Management's ELV Position: Q2 2026 in Review

Chilton Capital Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 37 shares — an estimated $10.8K sold.

Chilton Capital Management first reported a position in ELV in Q4 2023 and held it in 7 quarters. The position peaked at $11.9K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Chilton Capital Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Chilton Capital Management sold 37 Elevance Health shares in Q2 2026, an estimated $10.8K.
  • Chilton Capital Management first reported a position in Elevance Health in Q4 2023 and held it in 7 quarters.
  • Chilton Capital Management's Elevance Health position peaked at $11.9K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.